TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MGNX

MacroGenics Inc

Healthcare · Biotechnology

4.10$ -0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

MacroGenics Inc (MGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 345 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MGNX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
340 298 248 201 264 262 225 245 271 257 218 345
291 251 203 157 222 217 182 205 232 220 183 322
90 101 80 84 180 183 146 131 80 57 67 114
256 230 184 140 200 202 154 176 146 190 154 173
25 10 7.2 6.2 8.8 4.3 11 13 69 13 10 144
1.1 1.2 1.2 1.1 3.2 0.0 9.4 9.3 8.8 7.9 9.5
146 146 142 143 144 146 145 199 204 201 197 303
51 56 56 58 59 56 55 39 44 43 96 109
3.9 3.8 4.1 4.4 4.7 4.9 5.4 5.1 5.1 5.2 5.2 5.0
3.3 6.4 11 5.2 6.6 5.0 6.6 4.7 5.9 4.8 4.3 3.4
194 153 106 58 120 116 79 47 67 56 21 43
-1,057 -1,103 -1,155 -1,211 -1,154 -1,170 -1,211 -1,247 -1,230 -1,244 -1,281 -1,262
62 62 62 63 63 63 63 63 63 63 63 64

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?